Probucol prevents blood–brain barrier dysfunction in wild‐type mice induced by saturated fat or cholesterol feeding
- 21 November 2012
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 40 (1) , 45-52
Abstract
Summary: Dysfunction of the blood–brain barrier (BBB) is an early pathological feature of vascular dementia and Alzheimer's disease (AD) and is triggered by inflammatory stimuli. Probucol is a lipid‐lowering agent with potent anti‐oxidant properties once commonly used for the treatment of cardiovascular disease. Probucol therapy was found to stabilize cognitive symptoms in elderly AD patients, whereas in amyloid transgenic mice probucol was shown to attenuate amyloidosis. However, the mechanisms underlying the effects of probucol have note been determined. In the present study we investigated whether probucol can prevent BBB disturbances induced by chronic ingestion of proinflammatory diets enriched with either 20% (w/w) saturated fats (SFA) or 1% (w/w) cholesterol. Mice were fed the diets for 12 weeks before they were killed and BBB integrity was measured. Mice maintained on either the SFA‐ or cholesterol‐supplemented diets were found to have a 30‐ and sevenfold greater likelihood of BBB dysfunction, respectively, as determined by the parenchymal extravasation of plasma‐derived immunoglobulins and endogenous lipoprotein enrichment with β‐amyloid. In contrast, mice fed the SFA‐ or cholesterol‐enriched diets that also contained 1% (w/w) probucol showed no evidence of BBB disturbance. The parenchymal expression of glial fibrillary acidic protein, a marker of cerebrovascular inflammation, was significantly greater in mice fed the SFA‐enriched diet. Plasma lipid, β‐amyloid and apolipoprotein B levels were not increased by feeding of the SFA‐ or cholesterol‐enriched diets. However, mice fed the SFA‐ or cholesterol‐enriched diets did exhibit increased plasma non‐esterified fatty acid levels that were not reduced by probucol. The data suggest that probucol prevents disturbances of BBB induced by chronic ingestion of diets enriched in SFA or cholesterol by suppressing inflammatory pathways rather than by modulating plasma lipid homeostasis.Keywords
This publication has 51 references indexed in Scilit:
- Sphingosine Kinase 1 Deficiency Exacerbates LPS-Induced NeuroinflammationPLOS ONE, 2012
- Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammationJournal of Neuroinflammation, 2011
- Vascular basis for brain degeneration: faltering controls and risk factors for dementiaNutrition Reviews, 2010
- Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- An Emerging Role of mTOR in Lipid BiosynthesisCurrent Biology, 2009
- Effects of short‐term Western diet on cerebral oxidative stress and diabetes related factors in APP × PS1 knock‐in miceJournal of Neurochemistry, 2009
- Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s diseaseJournal of Neurochemistry, 2008
- Brain region-specificity of palmitic acid-induced abnormalities associated with Alzheimer's diseaseBMC Research Notes, 2008
- Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?Journal of Experimental Medicine, 2006
- Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's diseaseNeuroscience Letters, 1992